A Dose Regimen-Finding Study to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Pharmacokinetics, and Activity of Oraxol in Subjects with Advanced Malignancies
Description: 
To determine the maximum tolerated dose (MTD) and dosing regimen of Oraxol in subjects with advanced malignancies.
Study Number: 

PH 278115

Phase: 
Early Phase
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT02730481

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.